ArunA Bio is organized around neurotherapeutic development with the firm's neural exosome therapeutic platform anchored in the capacity of the firm's proprietary neural exosomes to cross the blood brain barrier enables drugs and drug combinations to naturally target cells and treat patients with a range of neurological disorders. Aruna's being ale reliably manufacture exosomes at scale addresses one of the biggest challenges in the exosome field today The firm offers neuroscience products, including STEMEZ hNP1 neural progenitor cell expansion kits, which are used for various research applications, such as studies of neurotoxicity, neurogenesis, electrophysiology, and neurotransmitter and receptor functions; and STEMEZ hN2 that are normal human neurons grown as an adherent monolayer cell culture that is used in research, including disease studies, drug discovery, neurotoxicity, imaging, and high-throughput assays. The company also provides viPS Vector Kit for reprogramming somatic cells to generate induced pluripotent stem cells; and human stem cell systems that are used for applications and assays, including cellular model studies, high content screening, developmental studies, RNAi studies, and genetic manipulation. In addition, Aruna offers drug discovery and development services; and testing and assay services serving pharmaceutical companies, as well as academic researchers in brain and spinal cord research.
